7
73100
Specialized in biotechnology and the development of products for the life sciences, pharmaceutical, food, and cosmetic industries
About 73100
73100.pt is a Portuguese startup specializing in biotechnology, with a strong focus on developing innovative bio-based products and processes for the pharmaceutical and cosmetics industries. Since its inception in 2006, the company has leveraged its expertise in microbial fermentation and biopolymer chemistry to create high-value products.
One of the company's flagship products is AKNOUT, a dermocosmetic line specifically designed for acne-prone skin. This product line is based on the Chitin Glucan Complex biopolymer, a result of the company's extensive research and development (R&D) activities. AKNOUT is already available for purchase in Portugal, indicating a successful market entry.
73100.pt operates primarily in the pharmaceutical and cosmetics markets, serving clients who are looking for advanced, bio-based solutions. These clients include dermatologists, skincare clinics, pharmaceutical companies, and end consumers seeking effective skincare products.
The company's business model revolves around the development and commercialization of patented biopolymers and bio-based products. It holds a considerable intellectual property (IP) portfolio, including patents for the production of Galactose Rich Exopolysaccharide (GALACTOPOL) and Fucose Rich Exopolysaccharide (FucoPol). These patents not only protect the company's innovations but also provide a competitive edge in the market.
Revenue generation for 73100.pt comes from the sale of its dermocosmetic products, licensing of its patented technologies, and potentially from partnerships or collaborations with other companies in the pharmaceutical and cosmetics sectors.
In summary, 73100.pt is a highly specialized biotech company with a robust R&D foundation, a strong IP portfolio, and a clear focus on the pharmaceutical and cosmetics markets. Its innovative products and technologies position it well for continued growth and market penetration.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2006
- Headquarters
- Lisbon, Portugal
- Employees
- 2
- Open positions
- None listed
- Dealroom signal
- 26.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, SaaS, Biotechnology, Agritech, Chemistry, Platform, Primary Production, Biotech and Pharma, Seal of Excellence EC, Horizon Europe, DT and LS
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Jul 2017 | $1.5M | — | European Innovation Council | — |
| GRANTOther financing | Aug 2016 | $55K | — | European Commission | — |
Growth signals
Latest recorded traffic for 73100 is 610 monthly website visits, up 52.5% over the last three months. 73100's team declined 50% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 HQL PharmaceuticalsHighly Efficient Screening Tool of Chemical Libraries |
Rehovot, Israel | Operational | — | — | — |
 Legacy HealthcareBiopharma developing innovative botanical drugs in supportive oncology care and dermatology |
Epalinges, Switzerland | Operational | |||
 Bird-cBIRD-C is a privately held R&D biotechnology company based in Vienna, Austria |
Vienna, Austria | Operational | |||
 Phage BiotechA handful of pioneer in the field of Phage Therapy – Targeted Bacterial Eradication |
Rehovot, Israel | Closed | |||
 BiofBioftalmik is a biotechnology company focused on the field of ophthalmology |
Derio, Spain | Closed | |||
 Geneva BiotechDeveloping viral and non-viral DNA delivery systems |
Geneva, Switzerland | Operational | |||
 Se-cure PharmaceuticalsBiotech & Life Sciences |
Israel | Operational | |||
 PixCell MedicalDevelops, manufactures, and markets portable medical diagnostic products designed for use in point-of-care testing |
Yokneam Ilit, Israel | Acquired |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
European Commission
European Innovation Council
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about 73100 on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See 73100’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.